Related Experiment Videos
Obesity and cardiovascular disease
Antonio Pérez Pérez1, Juan Ybarra Muñoz, Vicente Blay Cortés
1Servicio de Endocrinología y Nutrición, Hospital de la Santa Creu i Sant Pau, S. Antoni M Claret 167, 08025 Barcelona. aperez@santpau.es
Public Health Nutrition
|November 21, 2007
Summary
Obesity significantly increases cardiovascular disease (CVD) risk. While weight management therapies can mitigate risk factors, ongoing trials are investigating the overall health benefits of weight loss for individuals with obesity.
Area of Science:
- Cardiology
- Endocrinology
- Public Health
Background:
- Obesity is a major global health concern, comparable to tobacco and alcohol in its negative health impact.
- Cardiovascular disease (CVD) is a primary medical consequence of obesity, particularly abdominal obesity.
- Obesity independently predicts clinical CVD events, including heart attack, coronary heart disease, heart failure, and stroke.
Purpose of the Study:
- To review the effects of obesity on cardiovascular risk factors and CVD.
- To summarize the efficacy of weight-loss interventions for managing obesity-related CVD risk.
Main Methods:
- A comprehensive Medline search was conducted using keywords: obesity, cardiovascular disease, body mass index, cardiovascular risk factors, type 2 diabetes, and metabolic syndrome.
- High-impact, English-language publications from the last 15 years were selected and analyzed.
Main Results:
- Ninety-nine relevant articles were reviewed, highlighting the link between obesity and CVD.
- Available weight management therapies show potential in improving or preventing obesity-related CVD risk factors.
- Ongoing large-scale clinical trials (e.g., Look-AHEAD, SCOUT) are examining the impact of weight loss on health outcomes.
Conclusions:
- Obesity poses a significant threat to cardiovascular health.
- Weight-loss interventions may offer benefits for cardiovascular risk factors, but further research is ongoing.
- Understanding the complex relationship between obesity, weight loss, and CVD is crucial for public health strategies.
Related Concept Videos
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:30Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
01:27Psychoneuroimmunology: Cardiovascular Disease
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
01:20Exercise and Cardiovascular Response
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...